ALLR Earnings

Quarterly EPS
$-7.71
Q3 2024
$-1.71
Q4 2024
$-0.25
Q1 2025
$-0.15
Q2 2025
$-0.19
Q3 2025
$-0.21
Q4 2025
$-0.17
Q1 2026
$-0.21
Q2 2026
Latest RevenueN/A
Latest Net Income-3405000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.210-3405000-40.0%
Q1 2026-$0.1725.0K-2750000+32.0%
Q4 2025-$0.21320.0K-3373000+87.7%
Q3 2025-$0.190-2806000+97.5%
Q2 2025-$0.150-2320000+95.5%
Q1 2025-$0.250-2732000+100.0%
Q4 2024-$1.710-7453000+98.7%
Q3 2024-$7.710-11590000+99.4%
Q2 2024-$3.340-1629000
Q1 2024-$664.160-3843000
Q4 2023-$130.130-1722000
Q3 2023-$1,345.940-4447000
Allarity Therapeutics (ALLR) — Earnings